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In herpesvirus infections, the virus persists for life but is contained through T-cell-mediated immune
surveillance. How this immune surveillance operates is poorly understood. Recent studies of other persistent
infections have indicated that virus persistence is associated with functional deficits in the CD8 T-cell
response. To test whether this is the case in a herpesvirus infection, we used a mutant murine gammaherpes-
virus that is defective in its ability to persist in the host. By comparing the immune response to this virus with
a revertant virus that can persist, we were able to dissect the changes in the antiviral CD8 T-cell response that
are induced by virus persistence. Surprisingly, persistently infected mice controlled a secondary challenge
infection more rapidly than nonpersistently infected mice, indicating enhanced rather than diminished effector
functions. Consistent with this, virus-specific CD8 T cells from these mice exhibited faster upregulation of the
cytotoxic mediator granzyme B. Another unexpected finding was that CD8 T cells from neither infection
responded efficiently to homeostatic cytokines. The unresponsiveness of the memory cells from the nonpersis-
tently infected mice appears to be linked to the prolonged replication of virus within the lungs. Other changes
seen in different chronic infection models were also observed, such as changes in Bcl-2 levels, interleukin-2
production, and the immunodominance hierarchy. These data show persistence of gammaherpesvirus type 68
alters the properties of CD8 T cells and illustrates that immune surveillance does not require CD8 T cells
with the same attributes as “classical” memory CD8 T cells.
Herpesviruses have a unique lifestyle in that they can very
effectively evade the immune response and persist in the in-
fected host indefinitely. The virus exists in a latent state un-
dergoing sporadic, often subclinical reactivation, which re-
leases infectious virions, allowing the virus to spread to new
hosts. Clinical reactivation during alphaherpesvirus infections,
such as herpes simplex virus and varicella-zoster virus, occurs
spontaneously, whereas clinical reactivation is only seen in the
context of immune suppression during beta- and gammaher-
pesvirus infections, such as cytomegalovirus and Epstein-Barr
virus. This illustrates that immune surveillance is very effective
for the latter viruses. However, the exact nature of this immune
surveillance is poorly understood.
Immunosurveillance during persistent viral infection is
thought to be mediated largely by T cells. However, most of
our knowledge about memory T cells is from acute virus in-
fections. These studies have shown that memory CD8 T cells
can be divided into two categories: effector memory cells
(TEM) and central memory cells (TCM) (32, 41, 42, 56, 59).
Effector memory cells are found predominantly in peripheral
tissues and display immediate effector functions. In contrast,
TCM cells are found predominantly in lymphoid tissue and lack
immediate effector function but have a higher proliferative
capacity and likely provide better longer-term immunity than
TEM cells (59). By comparing the gene expression in naive,
effector, and memory CD8 T cells, it appears that the full
pattern of gene expression associated with memory cells is only
attained several weeks following the clearance of viral antigen
(25). This includes up-regulation of antiapoptotic genes, such
as Bcl-2, genes for cytokines such as interleukin-2 (IL-2), and
up-regulation of the receptors for cytokines that enhance
memory cell survival, such as IL-15 or IL-7. Responsiveness to
these homeostatic cytokines is believed to be critical for mem-
ory cell survival, and expression of IL-7 receptor  (IL-7R)
specifically marks T cells that are destined to become memory
cells (23, 26). Responsiveness to IL-15 has been shown to be
critical for long-term memory cell survival following acute viral
infection (6, 9, 18, 24, 44, 49).
The functional consequences of persistent exposure to viral
antigens are poorly understood. From studies on human per-
sistent infections, it is clear that the memory T-cell response
does not fit easily into the central memory/effector memory
T-cell model (1, 2). In the murine lymphocytic choriomenin-
gitis virus (LCMV) model, a high dose of persistent virus
results in exhaustion of the T-cell response, leading to various
states of functional deficits or death of virus-specific CD8 T
cells (17, 34, 35, 50, 58). This is particularly marked in the
absence of CD4 T-cell help (62). Functional exhaustion does
not appear to be a feature of the T-cell response to herpesvi-
ruses, as the antiviral response is vigorous and apparently fully
functional. However, little is known about what, if any, impact
herpesvirus persistence has upon the memory CD8 T-cell
response. To date, the data from chronic virus infections in
mice and humans has been difficult to interpret. This is because
it is not clear whether the effects seen relate to the peculiarities
of T-cell priming inherent to a particular virus infection or
whether the effects are due to persistence of the virus. In this
report, we examine this issue in detail using a recently de-
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scribed mutant gammaherpesvirus that induces a strong im-
mune response but fails to persist in the host (16, 33). By
comparing this virus with a revertant strain that is competent
to persist, we show that viral persistence has a marked impact
on the properties of the CD8 T-cell response. However, the
ability of these cells to protect against virus infection is actually
enhanced by viral persistence.
MATERIALS AND METHODS
Mice and virus. C57BL/6 and BALB/c mice were purchased from the National
Cancer Institute (Bethesda, MD). A recombinant gammaherpesvirus type 68
(HV-68) strain containing a frameshift mutation in ORF73 (FS73) and the
revertant virus (FS73R) were obtained from Stacey Efstathiou (University of
Cambridge, United Kingdom) (16). A recombinant vaccinia virus expressing the
ORF61524-531/Kb epitope (rVV-p79) of HV-68 was obtained from Peter
Doherty (St. Jude Children’s Research Hospital, Tennessee) (8). For HV-68
infections, mice were infected intranasally (i.n.) with 400 PFU of FS73 or FS73R
under anesthesia with 2,2,2-tribromoethanol. For vaccinia virus challenge, mice
were given 1.5  106 PFU of rVV-p79 i.n. The Animal Care and Use Program
of Dartmouth College approved all animal experiments.
Tissue preparation. Single-cell suspensions of the spleen, lungs, and liver were
prepared by passage through cell strainers. Lung and liver suspensions were
resuspended in 80% isotonic Percoll and subsequently overlaid with 40% iso-
tonic Percoll. Samples were then centrifuged at 400  g for 25 min at 4°C. The
cells at the 80%-40% interface were collected, washed, and counted. To obtain
the bone marrow, thigh and shin bones were collected and the marrow was
flushed from the bones. Peripheral blood was obtained through a tail bleed and
collected into Hanks balanced salt solution containing 10 U/ml of heparin.
Spleen cells, bone marrow, and peripheral blood were depleted of erythrocytes
by treatment with buffered ammonium chloride, centrifuged, and counted.
Viral plaque assay. Infectious HV-68 virus titers in the lungs were deter-
mined by plaque assays as previously described (48). To measure vaccinia virus
titers, ovaries were homogenized in 1 ml of medium and then subjected to three
freeze-thaw cycles. Then the samples were serially diluted and assayed on mono-
layers of 143B cells in minimal volume. The virus was allowed to adsorb for 1 h
before being overlaid with carboxymethyl cellulose. After 2 days of incubation at
37°C, the assay mixtures were fixed with a solution of 50% acetone–50% meth-
anol for 15 min and stained with Giemsa stain for 4 h, and then the plaques were
enumerated microscopically.
Quantitative PCR for viral load and viral transcripts. Latent viral DNA was
quantified by quantitative fluorescent (QF)-PCR as previously described (54). To
analyze M2 gene expression, total RNA was isolated from spleen or lung tissue
using TRIzol (Invitrogen), followed by a secondary purification using the RNeasy
mini kit (QIAGEN, Valencia, CA) and utilizing on-column DNA digestion to get
rid of residual DNA. After column purification, 1 to 2 g of RNA was reverse
transcribed to cDNA using Omniscript RT (QIAGEN) with 100 g/ml of
oligo(dT) primer. QF-PCR was performed on 2.5 l of the cDNA mixture using
Platinum Quantitative PCR SuperMix-UDG, 400 nM primers, and 100 nM
FAM/Black Hole Quencher-1-labeled probes for either murine -actin or M2.
Primers and probes were as follows: murine -actin 3 primer, CAATAGTGA
TGACCTGGCCGT; murine -actin 5 primer, AGAGGGAAATCGTGCGT
GAC; murine -actin probe, TGCAATCTGGCTCAACGCCCG; M2 3 primer,
TGTTGGTTCGGGAGTTTAGG; M2 5 primer, CGAGGTCCTTAATGATG
TTGG; M2 probe, TCTGGCTCGACTGACAGTCCAGAAA. The samples
were subjected to 40 cycles of 15 s at 95°C and 1 min at 60°C. QF-PCR was
performed using a Bio-Rad iCycler.
Flow cytometry analysis. All surface and intracellular staining was performed
as previously described (37). For granzyme B staining, tetramer staining was
performed, and cells were fixed with 1% formaldehyde and permeabilized with
0.5% saponin. Cells were then stained with anti-human granzyme B (GB11;
Caltag, Burlingame, CA), washed, and then analyzed on a FACSCalibur. All
tetramers were made by the NIH Tetramer Core Facility (Emory University,
Atlanta, GA).
Intracellular staining for IFN- and IL-2. Cells were incubated with 1 g/ml
of the appropriate peptide plus 10 U/ml IL-2 and 10 g/ml brefeldin A (BFA) in
complete medium at 37°C for 5 h. Cells were stained with anti-CD8 antibody and
then fixed and rendered permeable before staining with antibodies to gamma
interferon (IFN-) and/or IL-2 as described previously (53). Analysis was per-
formed on a FACSCalibur flow cytometer using CellQuest software. For re-
stimulation of vaccinia virus-specific CD8 T cells, we used the DC2.4 dendritic
cell line infected in vitro with vaccinia virus, as previously described (52). The
DC2.4 dendritic cell line was obtained from the Dana Farber Cancer Institute.
Measuring responsiveness to cytokines in vitro. CD8 T cells were purified
using the EasySep murine CD8-positive selection kit (StemCell Technologies,
Vancouver, BC, Canada) to 95% CD8. Cells were then labeled with 0.5 M
carboxyfluorescein (diacetate) succinimidyl ester (CFSE) for 10 min at room
temperature and then extensively washed. Cells were then cultured in 96-well
plates at 5  106 cells/ml in the presence or absence of 500 U/ml IL-2 (Tecin;
National Cancer Institute), 125 ng/ml IL-7 (Peprotech, Rocky Hill, NJ), 125
ng/ml IL-15 (Peprotech), or 50 ng/ml IL-21 (R&D Systems, Minneapolis, MN)
for 4 days at 37°C. Antigen-specific cells were detected by intracellular cytokine
staining for IFN-, and CFSE dilution was monitored using a FACSCalibur flow
cytometer. The precursor frequency of the cells responding to the cytokines was
determined using the ModFit software.
Treatment of mice with antiserum and cidofovir. Immune serum was collected
from C57BL/6 mice which had been infected with HV-68 for 21 days postin-
fection. To shorten the infectious period of the FS73 infection, mice were treated
with 150 l of HV-68 immune serum intraperitoneally (i.p.) on day 6 postin-
fection. This was followed by treatment with 25 mg of cidofovir/kg of body weight
given subcutaneously as previously described (14). Cidofovir was administered
every other day from day 7 until day 28 postinfection.
Statistical analysis. All data were analyzed using Student’s t tests, and a P
value of less than 0.05 was considered significant. Viral titer data were log
transformed before performing Student’s t test, as recommended by Richardson
and Overbaugh (40).
RESULTS
In vivo analysis of the growth and establishment latency by
the FS73 strain of HV-68. Previous work has shown that
recombinant HV-68 viruses engineered to be deficient in the
ORF73 gene were unable to establish latency, although these
viruses replicated normally during the acute phase of the virus
infection (16, 33). By comparing this mutant with a revertant
virus in which the ORF73 gene was repaired, and therefore
could persist in the host, we could test whether herpesvirus
persistence influences the antiviral immune response. We ob-
tained a strain of HV-68 containing a frameshift mutation in
the ORF73 gene (FS73) along with a genetic revertant con-
taining the wild-type ORF73 gene (FS73R) (16). To ensure
these viruses grew similarly in our hands, we infected C57BL/6
mice i.n. with 400 PFU of either FS73 or FS73R and monitored
the viral titers within the lungs at days 7 and 14 postinfection.
We found that both FS73 and FS73R grew to similar titers at
day 7 postinfection, and both were markedly reduced by day 14
postinfection (Fig. 1A). Next, we sought to determine whether
the FS73 virus was able to establish latency. To do this,
C57BL/6 mice were infected with either of the two viruses, and
the number of viral genomes was quantified within the spleen
using QF-PCR for the ORF50 gene of HV-68. We found that,
at day 14 postinfection, only a few animals had detectable
levels of virus following FS73 infection and, at later time
points, no virus was detectable following FS73 infection (Fig.
1B). This contrasts with the FS73R infection, where virus was
reliably detected at all time points. Similarly, we could detect
no persistence of FS73 in the lungs at later time points (data
not shown). Thus, consistent with published reports, we con-
firmed that the FS73 mutant virus replicates as well as the
control virus but fails to persist in mice.
As the FS73 mutant fails to persist, we wished to test if
certain latency-associated events were altered in infected mice.
During the establishment of latency, mice develop an infec-
tious mononucleosis-like syndrome marked by a transient
splenomegaly and a dramatic expansion of the V4 CD8
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T-cell population (48, 51). To test if these events were atten-
uated in mice infected with the nonpersistent virus, C57BL/6
mice were infected with either the FS73 or the FS73R strain of
HV-68. At the times indicated, the number of spleen cells was
determined and the expansion of the V4 CD8 T-cell pop-
ulation was monitored within the blood, where this expansion
is most dramatic (51). Mice infected with the FS73R strain of
HV-68 displayed a transient splenomegaly (Fig. 1C) and ex-
pansion of the V4 CD8 T-cell population (Fig. 1D). In
contrast, infection with the FS73 strain of HV-68 resulted in
neither splenomegaly nor expansion of the V4 CD8 T-cell
population. Therefore, lymphocytosis normally associated with
persistent HV-68 infection was absent in mice infected with
the nonpersistent FS73 virus. Taken together with the virolog-
ical data, these data indicate that the FS73 mutant of HV-68
is unable to establish latency effectively and persist long-term
in the host, making this strain an effective tool to dissect the
effects of viral persistence on CD8 T-cell function.
CD8 T-cell expansion and memory during FS73 and
FS73R infection. Since little is known about the effects of
herpesvirus persistence on the size of the CD8 T-cell re-
sponse, we next monitored the CD8 T-cell response elicited
by both the nonpersistent FS73 strain and the persistent
FS73R strain of HV-68 over the first 90 days postinfection. In
C57BL/6 mice, two major epitopes have been defined within
lytic proteins, ORF6487-495/D
b and ORF61524-531/K
b (47). In
these experiments, C57BL/6 mice were infected i.n., and the T-
cell response against the ORF6487-495/D
b and ORF61524-531/K
b
epitopes was monitored using major histocompatibility com-
plex peptide tetramers. Examining the ORF61524-531/K
b re-
sponse, we found that both the FS73 and FS73R viruses in-
duced CD8 T-cell responses of similar frequency throughout
the primary response and into the memory phase (Fig. 2A),
although the total number of ORF61524-531/K
b-specific cells
was decreased at 21 and 28 days after infection due to the
lack of splenomegaly in FS73-infected mice (Fig. 2C). The
CD8 T-cell response against the ORF6487-495/D
b epitope
was similar for both viruses on days 10 and 14 postinfection.
However, on day 21 postinfection, the response induced by
the persistent and nonpersistent strains began to diverge.
Whereas the CD8 T-cell response induced by the nonper-
sistent FS73 virus continued to expand until day 21, the
response induced by the revertant virus began to contract
(Fig. 2B and D). Therefore, infection with the nonpersistent
FS73 virus resulted in ORF6487-495/D
b and ORF61524-531/K
b
being codominant, whereas after infection with the rever-
tant virus, the ORF61524-531/K
b response was strongly dom-
inant over that of ORF6487-495/D
b.
Since memory CD8 T cells are known to be found in every
organ of the body (21, 32), we also wanted to test if similar
differences in immunodominance were seen in other organs.
To do this, C57BL/6 mice were infected i.n. and left for 60
days. Then the peripheral blood, liver, lungs, and bone marrow
were collected and analyzed by tetramer staining for both the
FIG. 1. FS73 and FS73R grow similarly during lytic replication but fail to establish long-term latency. C57BL/6 mice were infected i.n. with 400
PFU of either the FS73 or FS73R strain of HV-68. (A) Growth of the viruses during the lytic phase of replication was measured in the lungs at
days 7 and 14 postinfection using a standard plaque assay. (B) The establishment and maintenance of latency within the spleens was measured by
QF-PCR for the ORF50 gene at days 14, 21, 28, and 42 postinfection. In addition, spleen cellularity (C) and expansion of the CD8 V4 T-cell
population (D) were measured at the indicated times points after infection, as these events are associated with the establishment of latency. Panels
A, C, and D show the average values for 4 mice per group, with the error bars each indicating one standard deviation. In panel B, each dot
represents an individual mouse, with 3 to 4 mice per group. In all graphs, open symbols represent mice infected with FS73R, and filled symbols
indicated mice infected with FS73. Data are representative of results from at least two experiments.
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FIG. 2. Virus persistence alters the CD8 T-cell immunodominance hierarchy in C57BL/6 mice. C57BL/6 mice were infected i.n. with 400 PFU
of either the nonpersistent FS73 or the persistent FS73R strain of HV-68 and then were analyzed by tetramer staining for either the
ORF61524-531/K
b or ORF6487-495/D
b population plus anti-CD8a and antibodies to the appropriate activation markers. The kinetics of the immune
response against the ORF61524-531/K
d epitope (A, C) and the ORF6487-495/D
d epitope (B, D) were monitored at the indicated times within the
spleen. In panels A and B the data are presented as percentages of antigen-specific CD8 T cells, while panels C and D present the same data
as the absolute numbers of antigen-specific CD8 T cells. Each symbol represents the average for 4 to 5 mice per group, with the error bars each
8306 OBAR ET AL. J. VIROL.
ORF6487-495/D
b and ORF61524-531/K
b epitopes. Similar to
what was observed in the spleen, the CD8 T-cell immu-
nodominance hierarchy was altered in all organs tested during
persistent infection (Fig. 2E).
Since viral persistence could result in the continual activa-
tion of the CD8 T cells to effector cytotoxic T lymphocytes
(CTLs), we examined the cell surface phenotype of CD8 T
cells from the spleen to determine if the populations in the two
infections were in different states of activation. We chose to
stain with a panel of the most commonly used markers for
identifying activated/memory CD8 T cells. At 14 days postin-
fection, antigen-specific CD8 T cells from both groups had
the same phenotype, CD44hi CD62Llo CD43hi Ly6chi (Fig. 2F),
as was expected considering the initial replication of these
viruses was the same during the acute infection. We did not
observe upregulation of CD25 and CD69 at day 14, likely
because these molecules are only transiently upregulated after
T-cell activation. At later time points, the phenotype of the
antigen-specific CD8 T cells induced by the nonpersistent
and persistent HV-68 infections was identical. This was true
at all time points tested during the persistent infection (31 to
120 days postinfection). The antigen-specific CD8 T cells
were uniformly CD44 and Ly6c but expressed lower levels
of CD43 (1B11) compared with the day 14 response (Fig. 2F).
Interestingly, the majority of the antigen-specific CD8 T cells
remained CD62Llo following infection with the nonpersistent
FS73, similar to what is seen with the persistent FS73R. Thus,
infection of mice with the nonpersistent or persistent strain of
HV-68 results in a robust CD8 T cell response that at later
time points results in cells of similar phenotypes even though
virus persists during FS73R infection.
Viral persistence is not responsible for the phenotypic dif-
ferences observed between lytic and latent antigen-specific
CD8 T cells. The effect of ORF73 deficiency on the expres-
sion of latency-associated genes and the corresponding im-
mune response to the gene products is not known. The M2
gene has been shown to be associated with viral latency. It is
expressed transiently around 14 days postinfection and con-
tains an H-2Kd-restricted CD8 T-cell epitope (22). There-
fore, we sought to determine whether the M2 gene was still
expressed following FS73 infection and whether the CD8
T-cell response to this protein was mounted effectively. These
studies used the BALB/c (H-2d) mouse strain, as no CD8
T-cell responses to latent antigens have been identified in
C57BL/6 mice. BALB/c mice were infected with either the
nonpersistent FS73 or persistent FS73R virus, and viral gene
expression was monitored at day 14 postinfection in the spleen,
while the M291-99/K
d-specific CD8 T cell response was exam-
ined at days 18 and 188 postinfection in the spleen. We found
that expression of the latency-associated M2 gene was decreased
approximately fivefold in the absence of ORF73 (Fig. 3A). An
M291-99/K
d-specific CD8 T-cell response was present by day 18
postinfection in both groups, although it was greater in size in the
FS73R group (Fig. 3B). By day 188 postinfection, the M291-99/
Kd-specific CD8 T-cell population was of equivalent size in both
groups.
Previously, we had reported that CD8 T cells specific for
lytic antigens had a markedly different cell surface phenotype
than those recognizing latent antigens. CD8 T cells recogniz-
ing the latency-associated M2 protein were predominantly
CD62Lhi or CD43hi (1B11), whereas those recognizing the lytic
cycle antigen ORF65 expressed significantly lower levels of
these markers (36). In that report, we hypothesized that the
different cell surface phenotype was due to the persistence of
the virus and differing levels of viral antigen seen by the re-
sponding cells during latency. As the FS73 strain of HV-68 is
unable to establish latency, we were able to test this directly.
Spleen cells from BALB/c mice infected with either the non-
persistent FS73 or persistent FS73R virus for 60 days were
stained with either the M291-99/K
d or ORF65131-140/D
d tet-
ramer plus antibodies to CD8 and activation/memory markers.
We found that viral persistence had no impact on the pheno-
type of the lytic or latent antigen-specific CD8 T cells at late
time points (Fig. 3C), demonstrating that viral persistence was
not responsible for these phenotypic differences.
Memory CD8 T cells turn over faster during persistent
viral infection. To measure the proliferation of the antigen-
specific CD8 T cells, C57BL/6 mice were infected with either
the persistent FS73R or nonpersistent FS73 virus for60 days,
at which time they were treated with bromodeoxyuridine
(BrdU) in their drinking water for 10 days. BrdU incorporation
was then measured in virus-specific CD8 T cells, which were
identified using tetramer staining. As shown in Fig. 4, ap-
proximately twice the proportion of antigen-specific CD8
T cells were BrdU in the FS73R group compared with the
FS73 group. This difference was observed with both the
ORF6487-495/D
b and ORF61524-531/K
b epitopes. Therefore,
the turnover of the antigen-specific CD8 T cells was signifi-
cantly faster in the presence of persistent infection.
Bcl-2 is expressed at lower levels during persistent HV-68
infection. Studies examining the maturation process of mem-
ory CD8 T cells indicate that complete maturation requires
the absence of antigen to gain a full memory phenotype (25,
59). One important characteristic of memory CD8 T cells is
their high level of antiapoptotic molecules, especially Bcl-2
(19). To address whether viral persistence affects the Bcl-2
levels found in antigen-specific CD8 T cells during viral la-
tency, spleen cells from C57BL/6 mice infected with either the
FS73 or FS73R virus for 60 days were stained with anti-CD8
and the appropriate tetramer, followed by intracellular stain-
indicating one standard deviation. (E) ORF61524-531/K
b- and ORF6487-495/D
b-specfic CD8 T cells were measured in a range of tissues at 60 days
postinfection. Plots are gated on CD8 T cells, with the values indicating the average percentages of antigen-specific CD8 T cells for that group
(4 mice per group) 	 1 standard deviation, while an asterisk (*) indicates a statistically significant difference between the two groups (P 
 0.05).
(F) The activation status of the antigen-specific CD8 T cells at late time points (60 days) was determined following either persistent FS73R or
nonpersistent FS73 infection. The filled gray histograms represent ORF61524-531/K
b-specific CD8 T cells from mice infected with the nonper-
sistent FS73 virus, whereas the solid black lines represent this population from mice infected with the persistent FS73R virus. Data are
representative of results from at least two experiments.
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ing to detect Bcl-2. We found that Bcl-2 levels in the
ORF61524-531/K
b-specific memory CD8 T cells during persis-
tent FS73R infection were significantly lower than the levels
found following nonpersistent FS73 infection (Fig. 5). Similar
results were also obtained when the ORF6487-495/D
b epitope
was examined (data not shown).
Fewer antigen-specific CD8 T cells can produce IL-2 dur-
ing persistent infection. The ability to produce IL-2 is an
important function of memory CD8 T cells, as this cytokine is
required for rapid expansion following secondary exposure to
FIG. 3. Expression of a latency-associated gene is decreased, but
the CD8 T cell response is induced and has a similar phenotype
during long-term latency. BALB/c mice were infected i.n. with 400
PFU of either the nonpersistent FS73 or persistent FS73R strain of
HV-68. (A) At 14 days postinfection, spleen samples were taken and
total RNA was isolated as described in Materials and Methods. The
level of M2 gene expression was determined by QF-PCR and was
normalized to -actin expression. Data are expressed as the mean
relative expression of the group, with the expression level in the FS73R
group being defined as 1.0 and the data ranges (lowest and highest
values) were as follows: FS73, 0.11 to 0.34; FS73R, 0.14 to 6.82.
(B) The M291-99/K
d-specific CD8 T-cell population was monitored
during both expansion and long-term latency by tetramer staining.
Data represent the average percentages of M291-99/K
d-specific CD8 T
cells in the spleen, with the error bars each indicating one standard
deviation. (C) The phenotype of lytic versus latent antigen-specific
memory CD8 T cells was compared in BALB/c mice infected with
either the FS73 or FS73R virus for 60 days. The graph shows the
average percentages of M2- or ORF65-specific CD8 T cells that
express either CD62L or CD43 (1B11), and the error bar indicates one
standard deviation. Data are representative of results from at least two
experiments.
FIG. 4. In vivo turnover of virus-specific CD8 T cells is increased
during FS73R infection. C57BL/6 mice that had been infected with
either the persistent FS73R or nonpersistent FS73 virus for 60 days
were treated with 0.8 mg/ml BrdU in their drinking water for 10 days.
Spleen cells were then stained with either the ORF61524-531/K
b or
ORF6487-495/D
b tetramer followed by anti-CD8a antibody. Cells were
then fixed, rendered permeable, DNA digested, and stained with an
anti-BrdU antibody. The graph represents the average percentage of
antigen-specific CD8 T cells that have incorporated BrdU into their
DNA. Each group contained 4 mice, and the error bars each indicate
one standard deviation. Black bars represent mice infected with the
nonpersistent FS73 virus, whereas white bars represent mice infected
with the persistent FS73R virus. Data are representative of the results
from two experiments.
FIG. 5. Virus persistence results in antigen-specific CD8 T cells
which fail to completely up-regulate Bcl-2. C57BL/6 mice were in-
fected i.n. with 400 PFU of either the persistent FS73R or nonpersis-
tent FS73 virus for 60 days. Spleen cells were stained with the
ORF61524-531/K
b tetramer plus anti-CD8a antibody. Cells were then
fixed, rendered permeable, and stained with an anti-Bcl-2 antibody.
Data are shown as the mean fluorescent intensities (MFI) for Bcl-2
within the ORF61524-531/K
d-specific CD8 T cells. The graph depicts
the average for each group of 4 mice, with the error bars each indi-
cating one standard deviation. The black bar represents mice infected
with the nonpersistent FS73 virus, whereas the white bar represents
mice infected with the persistent FS73R virus. Data are representative
of results from two experiments, with similar data obtained for the
ORF6487-495/D
b-specific population.
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antigen. In other systems, approximately 20% of memory
CD8 T cells produce IL-2 in response to antigen restimula-
tion (27). It has previously been shown in HV-68 infection
that the number of antigen-specific CD8 T cells observed by
tetramer analysis and the number of IFN--producing cells
detected using intracellular cytokine staining are equivalent (7,
46). Therefore, we identified antigen-specific CD8 T cells using
intracellular IFN- staining and also measured how many of
these cells produced IL-2. During the first 45 days postinfec-
tion, only a small proportion of cells in either group made IL-2
(Fig. 6); however, at 60 days postinfection and later, the pro-
portion of cells making IL-2 rose significantly in the FS73
group. In contrast, the proportion in the persistent FS73R
group remained low. These changes were observed for both
the ORF6487-495/D
b, and ORF61524-531/K
b-specific CD8 T-cell
populations. Therefore, virus persistence decreases the pro-
portion of virus-specific CD8 T cells that can produce IL-2.
Proliferation of antigen-specific CD8 T cells in response to
homeostatic cytokines in vitro. Following acute viral infec-
tions, memory CD8 T cells are maintained in the absence of
antigen due to their ability to proliferate in response to IL-15
(6, 9, 18, 24, 44, 49), although IL-7 can substitute for the
absence of IL-15 in lymphopenic mice (18, 39, 49). However,
we have shown that, during wild-type HV-68 infection, the
antigen-specific CD8 T cells appear hyporesponsive to these
cytokines and that these cells are actually maintained in the
absence of IL-15 (37). To examine whether this unresponsive-
ness to IL-15 and other members of the common -chain
cytokines was a result of viral persistence, CD8 T cells were
purified from C57BL/6 mice, which had been infected with
either the persistent FS73R or nonpersistent FS73 virus for
60 days. Cells were CFSE labeled and then cultured in vitro
for 4 days without antigen in the presence of IL-2, IL-7, or
IL-15. Antigen-specific CD8 T cells were identified by intra-
cellular cytokine staining for IFN-, and CFSE dilution was
monitored to assess proliferation in response to cytokines. As
a positive control, vaccinia virus-specific memory CD8 T cells
were shown to proliferate vigorously in response to IL-2 and
IL-15 at the concentrations we used (Fig. 7A). Surprisingly, we
found that antigen-specific CD8 T cells induced by both the
nonpersistent FS73 and persistent FS73R viruses responded
poorly to all cytokines tested (Fig. 7A). Proliferation in re-
sponse to IL-15 and IL-2 was reproducibly better in the anti-
gen-specific CD8 T cells induced by the nonpersistent FS73
virus; however, the difference was small. In addition, prolifer-
ation was not enhanced by the addition of IL-21, which has
been shown to synergize with IL-7 and IL-15 (63). Therefore,
CD8 T cells responding to both the persistent and nonper-
sistent gammaherpesviruses had a poor response to homeo-
static cytokines. One possible reason for this lack of prolifer-
ation could be reduced expression of the receptors for these
cytokines. To examine this issue, we took mice infected for
60 days with either the persistent or nonpersistent viruses
and analyzed the expression of IL-7R (CD127), IL-2/IL-
15R (CD122), and c receptor (CD132) on the antigen-spe-
cific CD8 T cells from the spleen. As expected, we found that
vaccinia virus-specific CD8 T cells expressed all three recep-
tors, whereas both nonpersistent and persistent HV-68 infec-
tion resulted in antigen-specific CD8 T cells which had a
heterogeneous expression of IL-7R and expressed lower lev-
els of IL-2/IL-15R but had normal levels of c receptor (Fig.
7B). This is consistent with the responsiveness of the antigen-
specific CD8 T cells to these cytokines. Levels of CD127 or
CD122 on the FS73 group did not change at later times postin-
fection, as at day 121 postinfection, both groups had the same
expression pattern of these markers (Fig. 7C). CD127 expres-
sion was slightly elevated in both groups relative to that seen
during the acute infection (day 14); however, levels of CD122
were similar at both time points.
Since the antigen-specific CD8 T cells induced by the non-
persistent strain of HV-68 were unable to undergo homeo-
static proliferation, we wanted to understand the mechanism
behind this impairment. Comparing the viral replication kinet-
ics of a typical acute infection (i.e., LCMV, vesicular stomatitis
virus [VSV], or vaccinia virus) with the nonpersistent strain of
HV-68, we noticed that infection with the nonpersistent
HV-68 resulted in prolonged viral replication (approximately
7 days versus 14 days, respectively). To test whether this pro-
longed acute replication of the nonpersistent FS73 virus was
responsible for the lack of homeostatic proliferation, we short-
ened the time period where infectious virus could be detected
using an antiviral treatment. C57BL/6 mice were infected with
the FS73 virus, and then half of the mice were treated with
antiserum from HV-68-infected animals on day 6 postinfec-
tion, followed by treatment with the antiviral drug cidofovir for
2 weeks. We found that this treatment was able to rescue the
ability of the antigen-specific CD8 T cells to respond to ho-
meostatic cytokines (Fig. 7D).
FIG. 6. IL-2 production by virus-specific CD8 T cells in the pres-
ence or absence of persistent virus. C57BL/6 mice were infected i.n.
with 400 PFU of either persistent FS73R or nonpersistent FS73 virus
for the indicated period of time. Spleen cells were then restimulated
with ORF61524-531 peptide for 5 h. The cells were then stained with an
anti-CD8 antibody, fixed, rendered permeable, and stained with anti-
IFN- and anti-IL-2 antibodies. Each symbol is the average for the
group (4 mice per group) and represents the percentage of cells that
produce IL-2 in addition to IFN-. The open circles represent the
persistent FS73R infection, whereas the filled circles represent the
nonpersistent FS73 infection. Asterisks (**) indicate a statistically
significant difference between the groups (P 
 0.05). Data are repre-
sentative of results from at least three experiments, with similar data
obtained using the ORF6487-495 peptide.
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Antigen-specific CD8 T cells induced by persistent infec-
tion afford better protection from virus rechallenge than those
induced by acute infection. Since the purpose of memory T-cell
populations is to protect the host from future infection, we
wanted to test whether the antigen-specific CD8 T cells fol-
lowing nonpersistent FS73 or persistent FS73R infection were
able to protect the mice against a secondary viral challenge.
HV-68-infected mice are very resistant to rechallenge with
the same virus, presumably due to a potent neutralizing anti-
body response. Therefore, we challenged mice that had been
infected with either the nonpersistent FS73 or persistent
FS73R virus for 60 days with a recombinant vaccinia virus
expressing the ORF61524-531/K
b epitope (rVV-p79). Two days
after i.p. challenge with rVV-79, we found that FS73 memory
mice had slightly reduced titers, while FS73R memory mice
had largely controlled the infection at this time (Fig. 8A). By
day 4 postchallenge, both the FS73 and FS73R memory pop-
ulations were able to control the vaccinia virus to the same
extent (Fig. 8A). This indicates that CD8 T cells from both
persistently and nonpersistently infected mice have potent an-
tiviral activity, but the cells from the persistently infected mice
were more effective at protecting against secondary challenge.
Equivalent viral titers were seen in all groups when mice were
infected with wild-type vaccinia virus (data not shown), ruling
out nonspecific effects associated with persistent HV-68 in-
fection. Two factors that contribute greatly to the efficiency of
controlling a secondary infection are the speed of expansion of
the responding T cells and the kinetics with which the antiviral
functions of the CD8 T cells are induced. We first examined
the expansion of the antigen-specific CD8 T cells at day 2 and
FIG. 7. In vitro proliferation of antigen-specific CD8 T cells in response to homeostatic cytokines is impaired following both FS73 and FS73R
infection. (A) C57BL/6 mice were infected with vaccinia virus, the persistent FS73R virus, or nonpersistent FS73 virus for 60 days. CD8 T cells
from the spleens were purified by magnetic bead selection (purity, 98% CD8), then labeled with CFSE, and cultured with 125 ng/ml IL-15, 125
ng/ml IL-7, or 500 U/ml IL-2 for 4 days. Antigen-specific CD8 T cells were then identified by intracellular IFN- staining, and CFSE dilution was
monitored. For each plot, the filled histogram is representative of no cytokine and the open histogram represents the addition of cytokine. The
numbers at the top of each plot represent the percentage of the starting population that has undergone at least one division. (B) Expression levels
of the IL-2/IL-15R, IL-7R, and c receptors on the antigen-specific CD8
 T cells from mice infected for 60 days were determined by tetramer
staining. For IL-7R, values represent the percentages of antigen-specific CD8 T cells expressing the receptor, whereas for IL-2/IL-15R and the
c receptor, the values are the mean fluorescence intensity (MFI). Asterisks (**) indicate a significant difference compared to the expression on
the vaccinia virus-specific CD8 T cells (P 
 0.01). (C) Expression of CD127 and CD122 during acute infection and at late times postinfection.
Filled histograms represent FS73R-infected mice; solid black lines represent FS73-infected mice. (D) CD8 T cells from the spleens of C57BL/6
mice infected with either vaccinia virus, the nonpersistent FS73, or the nonpersistent FS73 plus cidofovir treatment as described in Materials and
Methods were purified by magnetic beads (purity,98% CD8). Homeostatic proliferation in response to IL-15 was measured as described above.
For each plot, the filled histogram is representative of no cytokine and the open histogram represents the addition of cytokine. The numbers
represent percentages of the starting population that had undergone at least one division. These data are representative of results from at least
two experiments.
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day 4 postchallenge by tetramer analysis. No difference in the
expansion of the antigen-specific CD8 T cells was observed at
either time point (Fig. 8B). Next we examined the levels of
granzyme B, a key mediator of target cell cytolysis. Virus-
specific CD8 T cells from both the nonpersistent and persis-
tent infections expressed minimal granzyme B levels in the
absence of rVV-p79 challenge (Fig. 8C). At day 2 postchal-
lenge, virus-specific CD8 T cells from the persistently in-
fected mice had increased levels of granzyme B compared with
those from the nonpersistently infected mice (Fig. 8D). By day
4 postchallenge, both groups expressed high levels of granzyme
B. Thus, is appears that persistently infected mice are able to
more quickly reactivate CTL effector functions and control a
secondary infection more rapidly.
DISCUSSION
In this report we have shown that the CD8 T-cell response
is affected in several specific ways by persistent gammaherpes-
virus infection. Using a mutant virus that does not persist but
nevertheless induces a potent CD8 T-cell response, we were
able to compare directly between responses, which matured in
the presence or absence of virus persistence. Our data dem-
onstrate that virus persistence is associated with lower levels of
Bcl-2, a smaller proportion of cells capable of producing IL-2,
and a faster turnover of antigen-specific CD8 T cells. In
addition, the antigen-specific CD8 T cells found during the
persistent infection exhibited more potent antiviral effects than
those from the nonpersistent infection. Surprisingly, CD8 T
FIG. 8. Antigen-specific CD8 T cells induced by both FS73 and FS73R are protective against secondary viral challenge. C57BL/6 mice infected
with either the persistent FS73R or nonpersistent FS73 virus for 60 days were rechallenged with 1.5  106 PFU of rVV-p79 i.p. (A) Vaccinia
virus titers were measured in the ovaries using a standard plaque assay at day 2 or day 4 postchallenge. Each data point represents a single mouse,
and the bars indicate the means for each group. (B) The expansion of the ORF61524-531/K
b-specific CD8 T cells in the spleen was analyzed by
tetramer staining at both day 2 and day 4 postchallenge. Data are gated on CD8 T cells, and the values represent the average percentages of
ORF61524-531/K
b-specific T cells	 one standard deviation. (C) Granzyme B levels in mice infected with FS73 or FS73R for60 days postinfection.
(D) Reactivation of effector functions in ORF61524-531/K
b-specific CD8 T cells was monitored by staining for intracellular granzyme B at both
day 2 and day 4 postchallenge. The data are gated on the ORF61524-531/K
b-specific CD8 T cells, and the values represent the average mean
fluorescence intensities (MFI) 	 one standard deviation. The filled histograms represent the isotype control, while the open histograms represent
granzyme B staining. Asterisks (**) indicate a significant difference between the groups at the same time point (P 
 0.01). For all experiments,
the data are representative of the results from at least three experiments containing 4 to 6 mice per group.
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cells from neither the nonpersistently nor persistently infected
mice were able to undergo homeostatic proliferation, which
appears to be related to prolonged acute lung infection during
HV-68 infection.
Infection of mice with HV-68 results in a persistent latent
infection. During the latent infection, the antigen-specific
CD8 T cells are restimulated with antigen, as evidenced by
their increased turnover rate. One possible outcome of viral
antigen persistence is the continual activation of CD8 T cells
to become effector CTLs. However, we observed no evidence
of the continual presence of activated effector CTLs in the
persistently infected mice, as they did not express any early
activation molecules and had minimal amounts of stored lytic
granules, as determined by granzyme B expression. The ex-
pression of these molecules was similar to what was observed
for memory CD8 T cells reactive against vaccinia virus (data
not shown) and is similar to what was observed during acute
and chronic LCMV infection (26, 57).
Studies examining the differentiation of CD8 T cells into
memory cells have demonstrated that following the clearance
of antigen, effector CTLs progressively differentiate into effec-
tor memory cells and eventually into central memory cells (25,
59). Our data indicate that this may not always be the case, as
antigen-specific CD8 T cells induced by the nonpersistent
FS73 infection resulted in cells with the same phenotype as
those elicited during persistent HV-68 infection. Specifically,
the majority of those cells remained CD62Llo, which is reex-
pressed on central memory cells (59), and had a heterogeneous
expression of IL-7R, which is expressed at high levels on
memory cells following acute infections (23, 26). Impairment
in the phenotypical maturation to classical memory cells has
been observed in other systems, such as recombinant adeno-
virus infection, where the virus is present for approximately 3
weeks but then cleared (60). More recently, the model of TEM
cells converting to TCM cells has been challenged by several
reports which have shown that the TEM and TCM populations
may be largely distinct subsets of memory cells (5, 11, 31).
Epstein-Barr virus (EBV)-specific CD8 T cells in humans
are largely CD27 CD28 and considered to be at an early
stage of differentiation, similar to what was observed for influ-
enza-specific CD8 T cells (1, 2). The fact that both EBV and
influenza virus-specific memory CD8 T cells have the same
phenotype implies that virus persistence alone does not deter-
mine the cell surface phenotype. Although CD27 and CD28
are less useful markers of memory cell differentiation in mice,
our results indicate that the phenotype of the antigen-specific
CD8 T cells following nonpersistent or persistent HV-68
infection are identical, thus corroborating these human studies
and extending their findings to include the phenotype of latent
antigen-specific CD8 T cells. This was surprising, as we and
others had postulated that viral persistence in HV-68 and
EBV was responsible for the differences in the phenotype
observed between lytic and latent antigen-specific CD8 T
cells (13, 20, 36). We are currently trying to understand what
causes these phenotypic differences observed in both EBV and
HV-68 infection.
Another aspect of the CD8 T-cell response that viral per-
sistence could influence is the size of the resulting antigen-
specific T-cell response. In our system, the immune response
against the immunodominant epitope, ORF61524-531/K
b, was
induced and maintained at similar levels regardless of whether
the virus persisted in the host. This indicates that the persis-
tence of viral antigens, or other factors associated with persis-
tent infection, are not required to maintain the relatively high
level of virus-specific CD8 T cells observed in this model.
Interestingly, there was a change in the immunodominance
hierarchy when the virus failed to persist. After infection with
the nonpersistent FS73 mutant virus, the responses to both the
ORF61524-531/K
b and ORF6487-495/D
b epitopes were very sim-
ilar in magnitude, both during acute infection and at extended
times postinfection. However, the ORF6487-495/D
b-specific re-
sponse declined much sooner than the ORF61524-531/K
b-spe-
cific response (starting at day 14) during persistent infection.
This led to a much lower frequency of ORF6487-495/D
b-specific
cells during the long-term persistent infection. Similarly, an
altered immunodominance has been observed in other persis-
tent infections (50, 58). Regulation of the immunodominance
hierarchy is subject to a very complex interplay of many dif-
ferent factors (61), and how persistence of antigen impacts this
process is still very poorly understood.
Many factors can influence the immunodominance hierar-
chy during virus infection (61) We hypothesize that this altered
immunodominance hierarchy is due to a combination of two
factors, the kinetics of antigen presentation and inflammation
which occurs as a result of splenomegaly. During the HV-68
infection, both the ORF61524-531/K
b and ORF6487-495/D
b
epitopes are presented early after infection, but only the
ORF61524-531/K
b epitope is presented in the spleen at later
time points, during the establishment of latency (29). There-
fore, while the ORF6487-495/D
b response expands but subse-
quently contracts, the ORF61524-531/K
b response contracts less,
likely due to this second wave of antigen presentation. During
persistent infection, this contraction is probably due in part to
the pronounced splenomegaly, which likely involves the pro-
duction of inflammatory mediators such as IFN-, that have
been shown to induce contraction of the T-cell response (4).
However, in nonpersistent infection there is no splenomegaly
and also no second wave of presentation of the ORF61524-531/K
b
epitope, as the virus does not establish latency. Therefore, the
contraction of the two epitopes will be similar and survival of
the ORF61524-531/K
b population is not enhanced relative to the
ORF6487-495/D
b population, as there is no second wave of
antigen presentation.
Importantly, we have uncovered that viral persistence can
have both positive and negative effects on the maturation and
function of the responding CD8 T cells. Viral persistence
impaired the ability of antigen-specific CD8 T cells to up-
regulate Bcl-2 and resulted in a smaller proportion of those
cells being capable of producing IL-2. A reduction in the levels
of Bcl-2 and/or the ability of CD8 T cells to produce IL-2 has
also been reported following infection with chronic LCMV or
murine cytomegalovirus in mice (27, 45, 57) and human im-
munodeficiency virus, EBV, and cytomegalovirus infection in
humans (10, 30, 38, 43). Therefore, these may be general
events that occur during persistent virus infections. Thus, the
difference observed in our systems and others is likely a result
of chronic exposure to antigen. However, there could also be
other explanations for the changes we observed. Persistent
infection may be accompanied by a low-level inflammatory
response, which may play a role in shaping the maturation of
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the CD8 T-cell response. However, coinfection of mice with
both HV-68 and vaccinia virus had no impact on the devel-
opment of the CD8 T cells responding against vaccinia virus
(data not shown), which strongly argues against the idea that
the cytokine milieu during priming or persistence influences
memory cell maturation. In addition, the idea that antigen
persistence results in these defects is strongly supported by a
recent study where chronic antigen exposure from repeated
administration of incomplete Freund’s adjuvant and peptide
resulted in reduced levels of Bcl-2 and continued down-regu-
lation of IL-7R (28).
Our finding that the functional capabilities of the virus-
specific CD8 T cells are maintained during HV-68 persis-
tence is in sharp contrast to what is seen in other persistent
infections, where the continued presence of virus causes severe
impairments in antiviral effector functions (17, 34, 35, 50, 58).
The key difference which may account for these results is likely
the quantity of virus that the immune system is exposed to
during the persistent infection. In systems like chronic LCMV,
there is a high viral load for an extended period (58), whereas
during gammaherpesvirus infections, the viral load is extremely
low and gene expression is tightly regulated. Nevertheless, viral
reactivation does occur and is sensed by the T cells, as dem-
onstrated by the fact that the turnover rate of virus-specific
CD8 T cells doubles in the presence of persistent virus. This
low-level stimulation of the T cells is probably not sufficient for
the development of severe deficits in effector functions, but
nevertheless prevents the expression of some memory charac-
teristics, such as the ability to synthesize IL-2 or up-regulate
Bcl-2 as discussed. However, the question still remains as to
why HV-68 persistence would result in antigen-specific CD8
T cells that can afford better protection against subsequent
viral challenge? One possibility is that during the persistent
infection there is a low level of inflammation, producing type I
and type II interferons which can inhibit vaccinia virus growth
(39a). This is likely not the case, as infection of persistently
infected mice with the Western Reserve strain of vaccinia virus
resulted in the rapid growth of the virus, similar to what was
seen in the nonpersistently infected mice or naive mice (data
not shown). Recently, it has been shown that the number of
antigen-specific CD8 T cells present in the peripheral tissue
before challenge correlates with the clearance of vaccinia virus
from the host (3). Following either nonpersistent or persistent
HV-68 infection, we observed no statistically significant dif-
ferences in the number of antigen-specific CD8 T cells in any
of the tissue tested. Therefore, it is unlikely that the enhanced
clearance is due to an elevated precursor frequency at the time
of challenge. Finally, it is possible that viral reactivation only
occurs sporadically; thus, responding T cells are not continu-
ously exposed to antigen. Periodic exposure to antigen fol-
lowed by periods of rest would constantly restimulate the T-
cell response, perhaps resulting in T cells that are poised and
ready to initiate very rapid antiviral functions upon reexposure
to virus, such as their expression of granzyme B.
We had previously found that antigen-specific CD8 T cells
induced by HV-68 failed to undergo homeostatic prolifera-
tion in response to IL-7 or IL-15, but those cells had an in-
creased survival when cultured with those cytokines (37). Sur-
prisingly, in this study, we found that antigen-specific CD8 T
cells elicited even by a nonpersistent HV-68 infection re-
sponded poorly to homeostatic cytokines. Typically, following
acute infections, memory CD8 T cells gain the ability to be
maintained in the absence of antigen through their prolifera-
tion to IL-15 (6, 9, 18, 24, 44, 49), although IL-7 can compen-
sate for the lack of IL-15 in some circumstances (18, 39, 49).
However, following chronic LCMV infection, the resulting
memory CD8 T cells population is left unresponsive to these
homeostatic cytokines (57). This is at least partly due to their
lower expression of the receptors for both IL-7 and IL-15. In
contrast, memory CD8 T cells induced by acute LCMV in-
fection expressed high levels of both the IL-7R and IL-15R
complexes and are able to proliferate in response to these
cytokines without antigen (57). Similarly, a recent study exam-
ining antigen-specific CD8 T-cell responses in humans dem-
onstrated that CD8 T cells specific for cleared infections
(influenza and RSV) homogenously expressed high levels of
IL-7R, whereas those specific for cytomegalovirus and EBV
had a mixed expression for IL-7R (12, 55). Our results dem-
onstrate that, following either nonpersistent or persistent
HV-68 infection, the antigen-specific CD8 T cells express
lower levels IL-2/IL-15R and were heterogeneous in their
expression of IL-7R. These lower levels of IL-2/IL-15R and
IL-7R in our system were consistent with the finding that
neither group of virus-specific CD8 T cells responded effi-
ciently to homeostatic cytokines. However, other factors could
be playing a role in the unresponsiveness of these cells to
homeostatic cytokines, such as increased expression of SOCS
proteins, which have recently been shown to regulate homeo-
static proliferation (15) and need to be further explored in our
system. Therefore, our data argue that responsiveness to ho-
meostatic cytokines does not only correlate with the persis-
tence of virus but also varies according to the identity of the
virus. There are many differences between the HV-68 and
LCMV. These discrepancies between the two systems include
the viral replication kinetics, cellular tropism, and/or antigen-
presenting cells initiating the immune response, which singly or
in combination may result in the differences observed between
the systems. It appears that the length of the initial viral rep-
lication is important in establishing the responsiveness to ho-
meostatic cytokines, as shortening the length of viral replica-
tion following nonpersistent infection with FS73 allowed those
antigen-specific CD8 T cells to proliferate in response to
IL-15. Importantly, our data with the nonpersisting mutant
virus also show that, in this system, memory CD8 T cells do
not need to express high levels of IL-7 or IL-2/IL-15R to
persist long-term in the absence of antigen.
In conclusion, we present evidence that the persistence of a
gammaherpesvirus shapes the antiviral cellular immune re-
sponse. A mutant virus that fails to persist elicits a CD8 T-cell
response that has a marked shift in the immunodominance
hierarchy, expresses higher levels of an antiapoptotic protein,
and has an enhanced ability to produce IL-2. Surprisingly,
these CD8 T cells responded poorly to homeostatic cytokines
regardless of whether or not the virus persisted in the host,
indicating that, in the HV-68 infectious model, high levels of
IL-7R and IL-2/IL-15R are not always necessary for the
survival of memory CD8 T cells either in the presence or
absence of viral antigen. Finally, we show that viral persistence
actually enhances the ability of the virus-specific CD8 T cells
to mount a secondary response in vivo and resist challenge with
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a recombinant vaccinia virus. This work raises several interest-
ing questions, such as what factors are responsible for the
generation of these different types of memory cells? Does
continued antigen presentation by specific cell types influence
the character of the memory CD8 T-cell response? Also, it
will be interesting to determine if similar changes are observed
in the antiviral CD4 T-cell response in this system. These
questions and others will form the basis of our future investi-
gations.
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